Article

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

2021-03-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the Covid-19 pandemic. Evaluation of Covid-19 vaccine efficacy against SARS-CoV-2 variants is urgently needed to inform vaccine development and use. <h4>Methods</h4> In this phase 2a/b, multicenter, randomized, observer-blinded, placebo-controlled trial i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a2834072-e6ed-5cdd-99bc-52a02c02ff9d
DOI: 10.1101/2021.02.25.21252477

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 VariantDOI 10.1101/2021.02.25.21252477Read

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 VariantSemantic proximity Read

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South AfricaSemantic proximity Read

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 VaccineSemantic proximity Read

Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)Semantic proximity Read

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein VaccineSemantic proximity Read

Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) In Adults in a Phase 2/3, Observer-Blind, Randomised, Controlled StudySemantic proximity Read

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and MexicoSemantic proximity Read

Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03Semantic proximity Read

Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIVSemantic proximity Read

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1Semantic proximity Read

NVX-CoV2373 Vaccine Efficacy Against Hospitalization: A<i>post hoc</i>analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trialSemantic proximity Read

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity Read